Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain
Ji Wang, Caiguangxi Deng, Ming Liu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial
Rong Tang, Hui Zheng, Busen Wang, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 7, pp. 613-623
Open Access | Times Cited: 36
Transforming vaccinology
Rino Rappuoli, Galit Alter, Bali Pulendran
Cell (2024) Vol. 187, Iss. 19, pp. 5171-5194
Closed Access | Times Cited: 17
STING agonist-based ER-targeting molecules boost antigen cross-presentation
Xiafeng Wang, Zhangping Huang, Lixiao Xing, et al.
Nature (2025)
Open Access | Times Cited: 1
Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1
Xian Li, Mengxin Xu, Jingyi Yang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders
Jessica Denis, Annabelle Garnier, Laurence Cheutin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine
Viravarn Luvira, Punnee Pitisuttithum
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 283-293
Open Access | Times Cited: 4
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates
Deborah Cromer, Arnold Reynaldi, Ainslie Mitchell, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
A Hidden Guardian: The Stability and Spectrum of Antibody-Dependent Cell-Mediated Cytotoxicity in COVID-19 Response in Chinese Adults
Jinge Cao, Mengze Gan, Zhihao Zhang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 262-262
Open Access
Safety and immunogenicity of Ad5-nCoV immunization after three-dose priming with inactivated SARS-CoV-2 vaccine in Chinese adults
Hangjie Zhang, Nani Xu, Yu Xu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine
Ivan Odak, Lennart Riemann, Inga Sandrock, et al.
EBioMedicine (2023) Vol. 99, pp. 104947-104947
Open Access | Times Cited: 9
Heterologous booster vaccination enhances antibody responses to SARS-CoV-2 by improving Tfh function and increasing B-cell clonotype SHM frequency
Yanli Song, Jiaolei Wang, Zhihui Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Non-spike and spike-specific memory T cell responses after the third dose of inactivated COVID-19 vaccine
Ruoqiong Huang, Liyang Ying, Jiangmei Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SYS6006, as a fourth-dose booster following three doses of inactivated vaccines in healthy adults: an open-labeled Phase 1 trial
Yuzhou Gui, Ye Cao, Jiajin He, et al.
Life Metabolism (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 6
Current German Recommendations and International Research on the Use of COVID-19 Boosters among Health Care Providers in 2024: A Narrative Review
Poramate Pitak‐Arnnop, Popchai Ngamskulrungroj, Nithi Mahanonda, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 385-385
Open Access | Times Cited: 2
Modeling of antibody responses to COVID-19 vaccination in patients with rheumatoid arthritis
Yun Kyu Kim, Yunhee Choi, Ji In Jung, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Heterogeneity of SARS-CoV-2 immune responses after the nationwide Omicron wave in China
Jing Wu, Mingzheng Jiang, Jiwei Li, et al.
Microbiology Spectrum (2024)
Open Access | Times Cited: 1
Estimating cumulative infection rate of COVID-19 after adjusting the dynamic zero-COVID policy in China
Sijia Zhou, Miao Lai, Shuhan Tang, et al.
Infectious Disease Modelling (2024) Vol. 10, Iss. 2, pp. 429-438
Open Access | Times Cited: 1
Real-World Study: Hybrid Immunity against SARS-CoV-2 Influences the Antibody Levels and Persistency Lasting More than One Year
Sitthichai Kanokudom, Jira Chansaenroj, Suvichada Assawakosri, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1693-1693
Open Access | Times Cited: 3
Antibody Response to COVID-19 Vaccines in Healthcare Workers: Which One is More Successful? Homologous or Heterologous?
Zehra Çağla Karakoç, Didem Taşcıoğlu, Bülent Ediz, et al.
SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital (2023)
Open Access | Times Cited: 2
Inactivated SARS-CoV-2 Vaccine Booster Against Omicron Infection Among Quarantined Close Contacts
Di Liu, Siyang Feng, Feng Sha, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2339507-e2339507
Open Access | Times Cited: 2
A micro-electroporation/electrophoresis-based vaccine screening system reveals the impact of vaccination orders on cross-protective immunity
Yongyong Li, Jingshan Mo, Jing Liu, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 108086-108086
Open Access | Times Cited: 1
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates
Deborah Cromer, Arnold Reynaldi, Ainslie Hie, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The development of therapeutics and vaccines against COVID-19.
Tianyu Zhao, Zhiwei Wang, Zhen Tong, et al.
Diagnostic Microbiology and Infectious Disease (2024) Vol. 111, Iss. 3, pp. 116643-116643
Closed Access
Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders
Jessica Denis, Annabelle Garnier, Laurence Cheutin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Antibody response following the fourth SARS‐CoV‐2 vaccine dose during the Omicron wave in Brazil
Maria Francilene Souza Silva, Fátima de Cássia Evangelista de Oliveira, Ana Carolina Matias Dinelly Pinto, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access
Page 1 - Next Page

Scroll to top